MedicarePartD.guide

A non-government resource built from CMS public data

denosumab biosimilars on SilverScript Choice (S5601-062)

Jubbonti, Ospomyv and others

Covered.

Tier 4 (non-preferred drug). Quantity limit of 1 per 180 days.

$60.52
Patient pays / month, after deductible
$172.90
Patient pays / month, before the $615.00 deductible
$181.55
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

OSPOMYV 60 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $172.90 for a month.

Other Osteoporosis drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-062